Celaletdin Camcı

487 total citations
31 papers, 352 citations indexed

About

Celaletdin Camcı is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Celaletdin Camcı has authored 31 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Celaletdin Camcı's work include Cancer-related Molecular Pathways (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Celaletdin Camcı is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Celaletdin Camcı collaborates with scholars based in Türkiye, Switzerland and Saudi Arabia. Celaletdin Camcı's co-authors include Alper Sevinç, Gökmen Aktaş, Tülay Kuş, Mehmet Kalender, Seval Kul, Serdar Öztuzcu, Abdullah Tuncay Demiryürek, Mehmet Rami Helvacı, Ali Süner and Recep Bayraktar and has published in prestigious journals such as Journal of Clinical Oncology, Gene and Respiratory Medicine.

In The Last Decade

Celaletdin Camcı

26 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celaletdin Camcı Türkiye 11 154 97 69 49 46 31 352
Keiko Yagi Japan 12 85 0.6× 53 0.5× 176 2.6× 41 0.8× 29 0.6× 40 522
İbrahim Halil Türkbeyler Türkiye 11 89 0.6× 36 0.4× 47 0.7× 20 0.4× 17 0.4× 34 313
Utku Oflazoğlu Türkiye 11 154 1.0× 44 0.5× 58 0.8× 58 1.2× 25 0.5× 41 312
Silvana Anna Maria Urru Italy 10 75 0.5× 70 0.7× 86 1.2× 20 0.4× 7 0.2× 23 328
H. Vincent France 7 130 0.8× 67 0.7× 38 0.6× 26 0.5× 115 2.5× 14 365
M. González‐Barón Spain 9 213 1.4× 67 0.7× 35 0.5× 14 0.3× 7 0.2× 20 316
L. Geeraerts United States 7 162 1.1× 79 0.8× 95 1.4× 28 0.6× 8 0.2× 7 426
Shiro Imai Japan 13 89 0.6× 70 0.7× 96 1.4× 22 0.4× 10 0.2× 40 573
Anne E. Wyman United States 9 15 0.1× 120 1.2× 130 1.9× 38 0.8× 39 0.8× 11 380
A.J. Staal-van den Brekel Netherlands 9 133 0.9× 146 1.5× 77 1.1× 33 0.7× 23 0.5× 13 448

Countries citing papers authored by Celaletdin Camcı

Since Specialization
Citations

This map shows the geographic impact of Celaletdin Camcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celaletdin Camcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celaletdin Camcı more than expected).

Fields of papers citing papers by Celaletdin Camcı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celaletdin Camcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celaletdin Camcı. The network helps show where Celaletdin Camcı may publish in the future.

Co-authorship network of co-authors of Celaletdin Camcı

This figure shows the co-authorship network connecting the top 25 collaborators of Celaletdin Camcı. A scholar is included among the top collaborators of Celaletdin Camcı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celaletdin Camcı. Celaletdin Camcı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helvacı, Mehmet Rami, et al.. (2025). Metformin in the treatment of chronic renal disease. 23(1).
2.
3.
Helvacı, Mehmet Rami, et al.. (2023). Acute painful crises may be causes of sudden deaths in sickle cell diseases. 7 indexed citations
4.
5.
Helvacı, Mehmet Rami, Alper Sevinç, Celaletdin Camcı, et al.. (2021). Atherosclerotic Background of Cirrhosis in Sickle Cell Patients. 15(2).
6.
İğci, Mehri, İbrahim Bozgeyik, Recep Bayraktar, et al.. (2016). High-throughput screening of Sirtuin family of genes in breast cancer. Gene. 586(1). 123–128. 49 indexed citations
7.
Süner, Ali, Hakan Büyükhatipoğlu, Gökmen Aktaş, et al.. (2016). Polymorphisms in the <em>MTHFR</em> gene are associated with recurrence risk in lymph node-positive breast cancer patients. OncoTargets and Therapy. Volume 9. 5603–5609. 1 indexed citations
8.
9.
10.
Kuş, Tülay, et al.. (2016). Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review. Oncology Letters. 11(4). 2801–2805. 11 indexed citations
11.
Kuş, Tülay, Gökmen Aktaş, Gökay Alpak, et al.. (2015). Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study. Supportive Care in Cancer. 24(5). 2085–2091. 17 indexed citations
12.
Kuş, Tülay, et al.. (2015). Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. OncoTargets and Therapy. 8. 1341–1341. 10 indexed citations
13.
Kuş, Tülay, Gökmen Aktaş, Mehmet Kalender, et al.. (2015). Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib. OncoTargets and Therapy. 8. 3749–3749. 7 indexed citations
14.
Göğebakan, Bülent, Recep Bayraktar, Ali Süner, et al.. (2014). Do Fasudil and Y-27632 affect the level of transient receptor potential (TRP) gene expressions in breast cancer cell lines?. Tumor Biology. 35(8). 8033–8041. 10 indexed citations
15.
Büyükhatipoğlu, Hakan, Ali Süner, Alper Sevinç, et al.. (2014). Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. Journal of Cancer Research and Therapeutics. 10(4). 962–962. 17 indexed citations
16.
Camcı, Celaletdin. (2014). The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer. Medical Science Monitor. 20. 1419–1425. 12 indexed citations
17.
Sarı, İbrahim, et al.. (2013). Role of Rho-Kinase Gene Polymorphisms and Protein Expressions in Colorectal Cancer Development. Pathobiology. 80(3). 138–145. 19 indexed citations
18.
İğci, Mehri, Ecir Ali Çakmak, Serdar Öztuzcu, et al.. (2012). Mutational Screening of the SOCS3 Gene Promoter in Metastatic Colorectal Cancer Patients. Genetic Testing and Molecular Biomarkers. 16(12). 1395–1400. 6 indexed citations
19.
Oğuz, Eli̇f, Belgin Alaşehirli, Yavuz Pehlivan, et al.. (2012). Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet’s disease. Translational research. 160(6). 428–434. 10 indexed citations
20.
Helvacı, Mehmet Rami, Hasan Kaya, Alper Sevinç, & Celaletdin Camcı. (2009). BODY WEIGHT AND WHITE COAT HYPERTENSION. Pakistan Journal of Medical Sciences. 25(6). 916–921. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiko Yagi Breakdown of academic impact, for papers by İbrahim Halil Türkbeyler Breakdown of academic impact, for papers by Utku Oflazoğlu Breakdown of academic impact, for papers by Silvana Anna Maria Urru Breakdown of academic impact, for papers by H. Vincent Breakdown of academic impact, for papers by M. González‐Barón Breakdown of academic impact, for papers by L. Geeraerts Breakdown of academic impact, for papers by Shiro Imai Breakdown of academic impact, for papers by Anne E. Wyman Breakdown of academic impact, for papers by A.J. Staal-van den Brekel
Rankless by CCL
2026